Rehabilitation of women after artificial abortions

Abstract

DOI: 10.52705/2788-6190-2026-02-6
УДК 618.39-085-089.888.14-036.82

The objective: to develop and implement a complex of rehabilitation measures for women after artificial abortions.
Materials and methods. The object of our study was a group of 540 women after artificial termination of pregnancy. The patients were divided into two groups. The main group included 510 studied women whose pregnancy termination was performed followed by patient follow-up calls. A portion of the women (n = 30) underwent conventional hormonal research. Based on the analysis of medical documentation and dispensary examination of women in the main group, the frequency of dishormonal breast diseases (DHBD) after medical abortion was revealed, and the significance of risk factors was assessed; taking into account the data obtained, a test group of 30 women with the highest risk of developing dishormonal breast diseases after medical abortion was formed for rehabilitation. The complex of conducted studies included clinical, laboratory, and instrumental methods.
Results. When studying the hormonal status, it was found that the concentration of estradiol increases in parallel with the increase in the degree of dysplasia; in contrast, the level of progesterone-the main estrogen antagonist that inhibits proliferative-dysplastic processes - steadily decreases as the degree of epithelial dysplasia increases. Analysis of the nature of the disturbances showed that with the deepening of the degree of dysplasia, the number of patients with anovulatory cycles and a shortened luteal phase increases, while the number of patients with hypohormonal-type disturbances decreases. Based on the cyclicity of menstrual function, characterized by changes in proliferative and secretory processes, we applied a combination of estrogens and progestins for the treatment of proliferative dysplasias combined with hypohormonal syndrome, i.e., deficiency of both phases of the menstrual cycle. The administration of cyclic hormone therapy in physiological doses exerts a regulatory effect on the gonadotropic function of the pituitary gland and provides a substitution effect.
Conclusions. The prophylactic use of homeopathic or hormonal drugs after medical abortion significantly reduces the risk of DHBD (p < 0,05). Therefore, rehabilitation-the prevention of DHBD after medical abortion-is a justified and necessary measure. If the administration of a hormonal drug to a woman after termination of pregnancy is impossible due to the presence of extragenital pathology or the woman’s reluctance to undergo hormone therapy, a homeopathic drug is the drug of choice in such cases.